Unsere Publikationen

Integrating large language models in care, research, and education in multiple sclerosis management

Link
https://doi.org/10.1177/13524585241277376
Tags
Multiple SkleroseManagement & ScienceeHealth
Jahr
2024
Autoren
Inojosa H, Voigt I, Wenk J, Ferber D, Wiest I, Antweiler D, Weicken E, Gilbert S, Kather JN, Akgün K, Ziemssen T.
Verlag
Mult Scler. 2024 Sep 23:13524585241277376.
Zum Eintrag

Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis

Link
https://doi.org/10.3389/fphar.2024.1431380
Tags
Multiple SkleroseMS BehandlungAutonomes Nervensystem & NeuroendokrinologieHerzratenvariabilitätBaroreflexsensitivität
Jahr
2024
Autoren
Constantinescu V, Haase R, Akgün K, Ziemssen T.
Verlag
Front. Pharmacol. 2024. 15:1431380.
Zum Eintrag

A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network

Link
https://doi.org/10.1016/j.msard.2024.105847
Tags
Multiple SkleroseManagement & ScienceeHealth
Jahr
2024
Autoren
Hersh CM, Sun Z, Conway DS, Sotirchos ES, Fitzgerald KC, Hua LH, Ziemssen T, Naismith RT, Pellegrini F, Grossman C, Campbell N.
Verlag
Mult Scler Relat Disord. 2024 Sep 2;91:105847.
Zum Eintrag

COVID-19 and multiple sclerosis: challenges and lessons for patient care

Link
https://doi.org/10.1016/j.lanepe.2024.100979
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2024
Autoren
Prosperini L, Arrambide G, Celius EG, Goletti D, Killestein J, Kos D, Lavorgna L, Louapre C, Somarni MP, Stastna D, Ziemssen T, Di Filippo M.
Verlag
Lancet Reg Health Eur. 2024;44:100979
Zum Eintrag

A future of AI-driven personalized care for people with multiple sclerosis

Link
https://doi.org/10.3389/fimmu.2024.1446748
Tags
Multiple SkleroseMS BehandlungManagement & ScienceeHealth
Jahr
2024
Autoren
Praet J, Anderhalten L, Comi G, Horakova D, Ziemssen T, Vermersch P, Lukas C, van Leemput K, Steppe M, Aguilera C, Kadas EM, Bertrand A, van Rampelbergh J, de Boer E, Zingler V, Smeets D, Ribbens A, Paul F.
Verlag
Front. Immunol. 2024. 15:1446748.
Zum Eintrag

Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374

Link
https://doi.org/10.3390/vaccines12080911
Tags
Multiple SkleroseNeuroimmunologie
Jahr
2024
Autoren
Ziemssen T, Groth M, Winkelmann VE, Bopp T.
Verlag
Vaccines 2023, 11, 1374. Vaccines. 2024; 12(8):911.
Zum Eintrag

Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons

Link
https://doi.org/10.57264/cer-2023-0161
Tags
Multiple SkleroseMS Behandlung
Jahr
2024
Autoren
Jiang T, Shanmugasundaram M, Božin I, Freedman MS, Lewin JB, Shen C, Ziemssen T, Arnold DL.
Verlag
J Comp Eff Res. 2024 Aug 19:e230161.
Zum Eintrag

Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER

Link
https://doi.org/10.1016/j.msard.2024.105812
Tags
Multiple SkleroseMS Behandlung
Jahr
2024
Autoren
Ziemssen T, Posevitz-Fejfár A, Chudecka A, Cepek L, Reifschneider G, Grothe C, Richter J, Wagner T, Müller B, Penner IK.
Verlag
Mult Scler Relat Disord. 2024 Aug 10;90:105812.
Zum Eintrag
1 2 3 4 5

Publikationen durchsuchen

Publikationen filtern

Filters
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Show AllHide
Jahr
-